|
Cancer Research KI is an umbrella organisation for all cancer research at the Karolinska Institutet, and comprises around 250 research groups spanning over 22 departments and three campuses.
The overarching aim of the programme is to combine cancer research with clinical oncology in order to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society. To read more about the organisation please click here and to register for our newsletter here.
|
|
|
|
|
|
|
A record number of applications were received this year for the Blue Sky Grant as well as the Translational Seed Funding grant! Cancer Research KI would like to thank each and every applicant for the time and thoughtfullness that was placed into the drafting of their applications. In total 40 Blue Sky applications were received, 5 of which were continuation grants from the same call announcement, along with 38 Translational Seed Funding grants. The comments received regarding the grants, upon external review, were very positive and overall the quality of the applications were deemed very good! Below we list the successful grant recipients for each call.
|
Blue Sky Grant for Innovative Cancer Research & Technology
|
|
These well-defined innovative cancer research pilot projects aim to demonstrate proof of principle and they should be of a "high risk – high reward" nature that cannot yet attract funding from conventional funding agencies. Further information about these projects are available here.
|
|
(top row left to right) Magda Bienko (MBB), Per Uhlén (MBB), Kirsty Spalding (MedH),
(bottom row left to right) Michael Landreh (MTC), Hong Qian (MedH), Bennie Lemmens (MBB)
|
Translational Seed Funding Grant
|
|
These projects aim to foster novel collaborations between basic and clinical scientists to address important problems in the area of translational cancer research. The two scientists should in a joint and collaborative format attack an important problem in translational cancer research, where the unique and complementary expertise from the two applicants is required to solve the research question. Further information about these projects are available here.
|
|
|
|
|
Vanessa Lundin (MedH)
Eva Hellström Lindberg (MedH)
|
|
|
Klas Blomgren (KBH)
Christer Betsholtz (MedH)
|
|
|
Anna Nilsson (KBH)
Martin Enge (Onc-Pat)
|
|
|
Robert Månsson (LabMed)
Marzia Palma (Onc-Pat)
|
|
|
Jenny Mjösberg (MedH)
Caroline Nordenvall (MMK)
|
|
|
Nicola Crosetto (MBB)
Theodoros Foukakis (Onc-Pat)
|
|
|
|
|
Congratulations to all successful grant recipients of 2020!
|
|
|
|
|
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, conducted by some 250 research groups at multiple campuses and departments. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
|
|
|
|
|
|
|
